Opioid Angst in the Pain Clinic: New Multisociety Consensus Guidelines

Friday, April 24, 2026

1:30 PM - 2:45 PM PT

Location: Harbor A-C, Level 2

Presenter(s)

Gregory D. Rudolf, MD

physician
Swedish Health Services
Seattle, Washington

Slides
Lynn Kohan, MD

Division Chief/, Program director
University of Virginia
Charlottesville, Virginia

Slides
Mark C. Bicket, MD, PhD, FASA

Associate Professor/Co-Director, Overdose Prevention Engagement Network
University of Michigan
Ann Arbor, Michigan

Slides

Most medical practitioners encounter patients with chronic pain who have experienced opioid-related challenges. The newly published ASRA Consensus Guideline outlines best practices for pain specialists in managing these patients. Whether you work in a pain specialty setting, or in primary care, physiatry, sports medicine, neurology, rheumatology, or psychiatry, the guideline's key statements and recommendations are pertinent to your practice. The session is structured around a longitudinal, interactive clinical case study, with guideline contents embedded throughout the discussion of the case.

Learning Objectives:

Learners will be able to:

Differentiate between OUD, CPOD, and physiologic dependence, and outline diagnostic and therapeutic implications in the chronic pain setting.
Design treatment plans incorporating buprenorphine or other MOUD for patients with coexisting pain and OUD, including initiation, maintenance, and perioperative considerations
Interpret and respond to urine drug screen findings and other objective screening for aberrant behaviors in the context of prescribed opioids or MOUD, using a patient-centered, evidence-based framework.

Disclosure(s):

Gregory D. Rudolf, MD: No financial relationships to disclose

Lynn Kohan, MD: Avanos: Consultant/Advisory Board (Ongoing); averitas: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); FUS mobile: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); vertex: Other Research Support (includes receipt of drugs, supplies, equipment or other in-kind support) (Ongoing)

Mark C. Bicket, MD, PhD, FASA: Daniels Health: Consultant/Advisory Board (Ongoing)